Toxic Torts


Roundup is an herbicide developed in 1974 by the Monsanto Co. that contains the active ingredient glyphosate. Roundup was originally developed for limited use and later became a popular herbicide for farmers, homeowners and gardeners.

Recently, Monsanto has become the subject of thousands of Roundup lawsuits due to the claim that the glyphosate may cause non-Hodgkin's Lymphoma and other types of cancer. Glyphosate is a non-selective herbicide that prevents plants from making proteins necessary for plant growth.

Glyphosate has never been included in the chemicals that the U.S. Environmental Protection Agency (EPA) tests for pesticides in human blood and tissue. As a result, there is limited data the EPA has available for the effects exposure to glyphosate has on people who use the product or live near areas where glyphosate is widely spread.

Studies Linking Roundup to Cancer

The manufacturer of RoundUp, Monsanto, has long maintained that the week killer does not cause cancer. However, several studies have linked exposure to Roundup to fatal medical conditions and an increased risk of developing cancer.

In March 1999, the American Cancer Society published a study that found there is an increased risk of people developing non-Hodgkin's lymphoma if they are exposed to Roundup and other herbicides. A 2008 study published by the International Journal of Cancer concluded that Roundup's active ingredient glyphosate causes a significant increase in the risk of developing lymphoma. In a 2014 study, researchers analyzed more than 3,400 farmworkers in the U.S. Midwest and found that higher rates of non-Hodgkin's lymphoma were linked with glyphosate use.

In 2015, the World Health Organization's International Agency for Research on Cancer (IARC) released a statement citing that it found strong evidence suggesting that glyphosate may be carcinogenic or contributes to causing cancer. IARC's research found glyphosate in the blood and urine of farmers exposed to the herbicide, including chromosome damage in the cells, increased risk of non-Hodgkin's lymphoma, and tumors in some animals.